1. Raza SA, Denholm SW, Wong JC. An audit of the management of otitis externa in an ENT casualty clinic. J Laryngol Otol. 1995; 109: 130-133.

2. Jinnouchi O et al. Antimicrobial and therapeutic effects of modified Burow’s solution on refractory otorrhea. Auris Nasus Larynx. 2012; 39:374-377.

3. Kashiwamura M et al. The efficacy of Burow’s solution as an ear preparation for the treatment of chronic ear infections. Otol Neurotol. 2004; 25:9-13.

4. Hyo Y et al. Antimicrobial effects of Burow’s solution on Staphylococcus aureus and Pseudomonas aeruginosa. Med Mol Morphol. 2012; 45: 66-71.

5. Lambert IJ et al. A comparison of the treatment of otitis externa with “Otosporin” and aluminium acetate: a report from a services practice in Cyprus. J Royal Coll General Practice 1981; 31:291-294.

6. Engstrom M. et al. Experiences of Burow’s Solution In spray form for Otitis Externa. Swedish ENT Journal, 2014; 3:19.

7. Rosenfeld et al. Clinical Practice Guideline US: Acute Otitis Externa. American Academy of Otolaryngology – Head and Neck Surgery Foundation 2014 Vol. 150 (IS) S1-S-24.

8. Barry V et al. BMJ 2021;372:n714

Press Contact Details

For all press and media enquiries please contact us here:

Kestrel Medical Ltd
Kestrel House
7 Moor Road
BH18 8AZ

Telephone: +44 1202 658 444

Email: [email protected]

Share This